CliffBio
biologic

hudquzco rubber panel,rubber panel t.r.u.e. test

Rubber Panel Thin-Layer Rapid Use Epicutaneous Patch Test

Loss of exclusivityMarch 2029projected — 12-year biologic exclusivity estimate
CompanySmartpractice Denmark Aps →See this company's full patent-cliff portfolio

Drug detail

Brand namehudquzco rubber panel,rubber panel t.r.u.e. test
Active ingredientRubber Panel Thin-Layer Rapid Use Epicutaneous Patch Test
StrengthPATCH TEST 5 ALLERGEN AND ALLERGEN MIX PATCHES AND A NEGATIVE CONTROL.
Dosage formPatch
RouteTopical
ModalityBiologic
FDA approvalMarch 2017
Marketing statusRx

More from Smartpractice Denmark Aps

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.

hudquzco rubber panel,rubber panel t.r.u.e. test patent cliff — loss of exclusivity March 2029 | CliffBio